Economic and Social Consequences of Diabetes There are many costs to the U.S. as more people are developing Diabetes at an increasing rate. The American Diabetes Association (ADA) researched and studied the costs to the healthcare systems and found that the costs were $174 billion in 2007 and rose to $245 billion in 2012. The cost of diabetes in the six years has risen to an outstanding 41%. The costs of Diabetes was broke down into two categories: medical costs and lost productivity. In the 2012 cost of $245 billion, $176 billion went to medical costs and $69 billion went to lost productivity (NCBI, 2013). The largest parts of the medical costs were hospital inpatient care, prescription medicine to treat the symptoms of Diabetes, antidiabetic agents and Diabetes supplies, doctor visits, and nursing facility stays. The diagnosed people with Diabetes usually spend on average $13,700 on medical bills of which approximately $7,900 is directly related to Diabetes. The cost for an average diabetic for medical costs is approximately 2.3 times larger than a non-diabetic with similar health profiles. To put the cost of Diabetes of the U.S. in perspective, about 1 in 5 dollars spent in the health care industry is related to the care and treatment of Diabetes (NCBI, 2013). The cost of Diabetes to the NHS is 14 billion Sterling Pounds (approximately $22.68 billion) every year. The cost per person with diabetes paid by the NHS is equal to $3,500 per year. The cost of Diabetes to the
The high dispersion of diabetes, especially through the aging population, comes at a considerable economic cost. Health care expenses for individuals with diabetes are 2.3 times greater than expenses for those without diabetes, and diabetes complications account for a significant amount of those cost.
This essay will focus on type 2 diabetes, which is becoming one of the fast growing chronic health conditions in the United Kingdom (UK). Approximately 700 people are diagnosed with type 2 diabetes each day in the UK (Diabetes Uk, (2014)a). It is costing the NHS about £10billion pounds each year to treat diabetes along with its complication and it is expected to rise in the next couple of years (Diabetes UK, (2014)b).
Costs incurred in the management of diabetes can be categorized as either direct or indirect, direct being the costs incurred in the management of the disease through medication, laboratory tests, physician and nursing care. Indirect cost, on the other hand, includes the cost of incurring a loss of productive individuals since the disease is associated with high mortality and morbidity. Over time the cost of management of diabetes has been rising with the increasing number of new cases of the disease. The cost of care for instance in 1980 ranged between 14 and 20 billion dollars. However, in 2002 the cost had increased to $132 billion, while the cost of managing the disease in the year 2007 was estimated at $174 billion in the United States
The percent change in spending for heart disease was attributed to a 68.6% increase in cost per treated case and a 30.3% increase in the population treated. Heart disease spending was the largest among 15 medical conditions experiencing the largest rise in spending. Interestingly, the rise in cost per treated hypertension case accounted for 60% of the overall growth in spending for hypertension compared with a 19% rise in treated prevalence of the disease. This was attributed to the emergence of new and more costly antihypertensive drugs. In contrast, 50% of the rise in health care spending for diabetes was a result of a rise in treated prevalence and only 24% was attributed to an increased cost per treated case. The total spending for diabetes increased from $8.6 billion in 1987 to $18.28 billion in 2000. Spending for diabetes will surely rise exponentially in the next 10 years because of the continued increase in prevalence of the population being treated and an increased cost per case as new diabetic drugs enter the pharmacologic armamentarium. The spending for diabetes and the spending for heart disease are obviously intertwined.
Type II Diabetes is a growing disease that according to Ley, Ardisson Korat, Qi, Tobias, Cuilin, Lu and ... Hu (2016) approximately 415 million adults are affected by this disease worldwide and in the United States in 2015, $348 million dollars was spent on treatment for
According to the video there are approximately 132 billion dollars a year spend to treat Diabetes. This is a significant amount, but the numbers amount of people that have diabetes continues to rise.
In America diabetes prevention and treatment cost are $242 billion in 2013 and that each it increases each year based on our Country spending (American Diabetes Associations, 2013), Therefore, a budget of $100 billion for the first-year budget for the year of 2019. Thus, establish a funding budget to be $100,000,000,000. Therefore, providing $200,000,000,000 each year for five years. From the 200,000,000,0000 established each year would base on funding, establish for materials, supplies and other resources need to further assist and improve 24 IHS diabetes clinics around the
Aleshia, your statement “direct costs are costs that can be easily associated with the production of a particular good or service”. The main cost component for outpatient diabetics’ care in both public and private has been medication costs. This is compatible also with what happened to the cost component of diabetics care in 2000 in Iran. It is estimated that direct medical costs of diabetes are 2–3 times higher than nondiabetic people (Davari, Boroumand, Amini, & Aslani, 2016). These additional costs are mainly attributed to the fact that diabetics are at high risk for blindness (retinopathy), kidney failures (nephropathy), neuropathy, foot ulcer and amputations, and disorder in sexual function(Davari, Boroumand, Amini, & Aslani, 2016). Cost
Currently, about 15% are children who are affected with this disorder (Healthline). However, Children can become young diabetics from deep-rooted family members or also from being overweight. Diabetes in childhood has an enormous impact on the society because of how much it is costing insurance companies and parents to treat childhood diabetics. The cost for all the medical supplies and treatment is around $ 37,750 to treat children diabetes every year (The Diabetes Council). This cost is a child with an excellent insurance
According to the CDC, as of 2010 diabetes effects about 1% of the population aged 20 years or less in the United States, with 13,000 children under the age of 18 diagnosed with type one diabetes per year. In 2007 it was found that an average expenditure was $11,744 per year. This amount includes direct attributes to diabetes such as medical costs, as well as lost work days, restricted activity and disability related to diabetes. This amount is “approximately 2.3 times higher than what expenditures would be in the absence of diabetes” (Center for Disease Control and Prevention (CDC), 2012).
In 2012 statistics show that 176 billion dollars where use for medication on diabetes.Diabetes is a complicated issue as demonstrated through its history, symptoms,treatments, and number of people affected by it.
On November 14, 2017, Gallup researchers and Sharecare, released The Cost of Diabetes in the U.S.: Economic and Well-Being Impact. This study indicates that diabetes has increased from 10.6% of U.S. adults in 2008 to 11.5% in 2017. Diabetes also results in 5.5 extra work days missed per year and an annual cost of $16 billion to U.S. employers. The study also indicates that 90% of Americans with Type 2 diabetes are overweight and there is a 26% decrease in diabetes risk for those employees who get 2.5 hours of exercise each week.
In some other country, it was estimated that approximately 90 million people were having type 2 diabetes with over 150 million people being prediabetic in 2010 (Yang W., et al 2010). Because diabetes is a prolonged chronic metabolic disease that causes many other complications, such as cardiovascular diseases, expenses spent on its treatment have placed a huge burden upon the economy and health systems worldwide (Ting Lu., et al
According to the IDF, 1 in 10 adults will have diabetes by 2040. The global cost of diabetes—based on statistics from the World Health Organization and the International Diabetes Federation Diabetes Atlas—was $1.31 trillion for 2015 [2].
Diabetes is one of the major leading causes of death in the Philippines. In 2002, it was the 6th leading cause of death in the United State alone. It cost US $ 132 billion per year for direct and indirect costs on the part of the